BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 110 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $596,700 | -19.8% | 27,000 | -21.1% | 0.00% | -50.0% |
| Q1 2023 | $743,850 | +232.3% | 34,200 | +178.0% | 0.00% | +100.0% |
| Q4 2022 | $223,860 | -90.9% | 12,300 | -88.7% | 0.00% | -85.7% |
| Q1 2022 | $2,465,000 | +600.3% | 108,459 | +1272.9% | 0.01% | +600.0% |
| Q2 2021 | $352,000 | -91.9% | 7,900 | -93.5% | 0.00% | -90.9% |
| Q1 2021 | $4,371,000 | +276.5% | 121,410 | +317.2% | 0.01% | +266.7% |
| Q4 2020 | $1,161,000 | +70.2% | 29,100 | -30.2% | 0.00% | 0.0% |
| Q2 2020 | $682,000 | -9.2% | 41,687 | -33.3% | 0.00% | 0.0% |
| Q4 2018 | $751,000 | -59.4% | 62,468 | -41.0% | 0.00% | -40.0% |
| Q3 2018 | $1,852,000 | +575.9% | 105,837 | +341.1% | 0.01% | +400.0% |
| Q2 2018 | $274,000 | +211.4% | 23,995 | +39.9% | 0.00% | – |
| Q1 2018 | $88,000 | -10.2% | 17,157 | +4.6% | 0.00% | – |
| Q4 2017 | $98,000 | – | 16,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
| Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
| Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
| Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
| GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
| Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
| Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
| Penbrook Management LLC | 41,500 | $917,150 | 0.66% |